Company: INMB
Filing Date: 2025-12-05
Form Type: 8-K
Source: 0001213900-25-118699
Chunk: 1

Company: Inmune Bio, Inc.
Filing Date: 2025-12-05
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial statements and Exhibits

(d) Exhibits.

  99.1      Press Release, dated December 1, 2025                                        
  99.2      Press Release, dated December 5, 2025                                        
 ─────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURES

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              INMUNE BIO INC.                               
  Date: December 5, 2025      By:                  /s/ David Moss           
                                                   David Moss               
                                                   Chief Executive Officer